These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3717115)

  • 1. A new therapy for portal systemic encephalopathy.
    Mendenhall CL; Rouster S; Marshall L; Weesner R
    Am J Gastroenterol; 1986 Jul; 81(7):540-3. PubMed ID: 3717115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial.
    Sushma S; Dasarathy S; Tandon RK; Jain S; Gupta S; Bhist MS
    Hepatology; 1992 Jul; 16(1):138-44. PubMed ID: 1618465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
    del Rosario M; Werlin SL; Lauer SJ
    J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial.
    Pedretti G; Calzetti C; Missale G; Fiaccadori F
    Ital J Gastroenterol; 1991 May; 23(4):175-8. PubMed ID: 1751811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of girls with ornithine transcarbamylase deficiency.
    Maestri NE; Brusilow SW; Clissold DB; Bassett SS
    N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sodium benzoate in portal-systemic-encephalopathy-induced blood ammonia normalization and clinical improvement. Interim report of a double-blind multicenter trial].
    Uribe M; Bosques F; Marín E; Cervera E; Gil S; Luis Poo J; Garcia Compeán D; Santoyo R; Huerta E; García-Ramos G; Cadena M; Merikansky A; Robledo J; Cortés M; Guevara A; López N; Aguilar A; Alejandra Ochoa E
    Rev Invest Clin; 1990 Jul; 42 Suppl():149-54. PubMed ID: 19256155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium benzoate and lactulose for the treatment of hepatic encephalopathy.
    Campollo O; Cortéz R; Gutiérrez M; Odor A; Muñoz RM
    J Hepatol; 1994 Dec; 21(6):1144. PubMed ID: 7699242
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of hepatic encephalopathy].
    Maier KP
    Dtsch Med Wochenschr; 1988 Dec; 113(48):1886-9. PubMed ID: 3058448
    [No Abstract]   [Full Text] [Related]  

  • 12. Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy?
    Ahuja NK; Ally WA; Caldwell SH
    Ann Hepatol; 2014; 13(2):179-86. PubMed ID: 24552859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sodium benzoate and sodium phenylacetate on brain serotonin turnover in the ornithine transcarbamylase-deficient sparse-fur mouse.
    Batshaw ML; Hyman SL; Coyle JT; Robinson MB; Qureshi IA; Mellits ED; Quaskey S
    Pediatr Res; 1988 Apr; 23(4):368-74. PubMed ID: 3374991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial.
    Uribe M; Farca A; Márquez MA; Garcĭa-Ramos G; Guevara L
    Gastroenterology; 1979 Jun; 76(6):1347-51. PubMed ID: 374177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy.
    Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD
    Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatic encephalopathy with metronidazole.
    Morgan MH; Read AE; Speller DC
    Gut; 1982 Jan; 23(1):1-7. PubMed ID: 7035298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of portal systemic encephalopathy: standard and new treatments.
    Marín E; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():141-8. PubMed ID: 19256154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.
    Uribe M; García-Ramos G; Ramos M; Valverde C; Márquez MA; Farca A; Guevara L
    Am J Gastroenterol; 1983 Aug; 78(8):517-22. PubMed ID: 6881119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.